These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2967468)

  • 1. 5 alpha-reductase activity in epithelium and stroma of prostates from intact and castrated dogs treated with androstenedione, the aromatase inhibitor 1-methyl-1,4-androstadiene-3,17-dione, and cyproterone acetate.
    Tunn S; Hochstrate H; Habenicht UF; Krieg M
    Prostate; 1988; 12(3):243-53. PubMed ID: 2967468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergic inhibitory effects of the aromatase inhibitor 1-methyl-androsta-1, 4-diene-3, 17-dione and the antiandrogen cyproterone acetate on androstenedione-induced hyperplastic effects in the prostates of castrated dogs.
    Habenicht UF; el Etreby MF
    Prostate; 1987; 11(2):133-43. PubMed ID: 2444953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective inhibition of androstenedione-induced prostate growth in intact beagle dogs by a combined treatment with the antiandrogen cyproterone acetate and the aromatase inhibitor 1-methyl-androsta-1,4-diene-3,17-dione (1-methyl-ADD).
    Habenicht UF; el Etreby MF
    Prostate; 1989; 14(4):309-22. PubMed ID: 2473459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetic analysis of androstenedione 5 alpha-reductase in epithelium and stroma of human prostate.
    Weisser H; Krieg M
    Steroids; 1997; 62(8-9):589-94. PubMed ID: 9432753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacologically induced ultrastructural and immunohistochemical changes in the prostate of the castrated dog.
    Aumüller G; Habenicht UF; el Etreby MF
    Prostate; 1987; 11(3):211-8. PubMed ID: 2446297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of aging on kinetic parameters of 3 alpha(beta)-hydroxysteroid oxidoreductases in epithelium and stroma of human normal and hyperplastic prostate.
    Tunn S; Haumann R; Hey J; Flüchter SH; Krieg M
    J Clin Endocrinol Metab; 1990 Sep; 71(3):732-9. PubMed ID: 1697599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetic parameters of 5 alpha-reductase activity in stroma and epithelium of normal, hyperplastic, and carcinomatous human prostates.
    Bruchovsky N; Rennie PS; Batzold FH; Goldenberg SL; Fletcher T; McLoughlin MG
    J Clin Endocrinol Metab; 1988 Oct; 67(4):806-16. PubMed ID: 2458378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of evidence for aromatase in human prostatic tissues: effects of 4-hydroxyandrostenedione and other inhibitors on androgen metabolism.
    Brodie AM; Son C; King DA; Meyer KM; Inkster SE
    Cancer Res; 1989 Dec; 49(23):6551-5. PubMed ID: 2479464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of influence of aromatase and 5 alpha-reductase inhibition on [3H]imipramine binding in the male rat brain.
    Sandrini M; Vergoni AV; Bertolini A
    J Endocrinol Invest; 1993 Oct; 16(9):679-81. PubMed ID: 8282962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selection of 19-(ethyldithio)-androst-4-ene-3,17-dione (ORG 30958): a potent aromatase inhibitor in vivo.
    Geelen JA; Deckers GH; van der Wardt JT; Loozen HJ; Tax LJ; Kloosterboer HJ
    J Steroid Biochem Mol Biol; 1991 Feb; 38(2):181-8. PubMed ID: 1825923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-androgen effects of the aromatase inhibitor, atamestane.
    Shao TC; Marcelli M; Kong A; Cunningham GR
    J Androl; 1995; 16(2):100-7. PubMed ID: 7559139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of a new steroidal aromatase inhibitor, TZA-2237, and/or chlormadinone acetate on hormone-induced and spontaneous canine benign prostatic hyperplasia.
    Ito K; Fukabori Y; Shibata Y; Suzuki K; Mieda M; Gotanda K; Honma S; Yamanaka H
    Eur J Endocrinol; 2000 Oct; 143(4):543-54. PubMed ID: 11022202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stromal 5 alpha-reductase activity is elevated in benign prostatic hyperplasia.
    Wilkin RP; Bruchovsky N; Shnitka TK; Rennie PS; Comeau TL
    Acta Endocrinol (Copenh); 1980 Jun; 94(2):284-8. PubMed ID: 6158242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical and histological studies on prostates in castrated dogs after treatment with androstanediol, oestradiol and cyproterone acetate.
    Tunn U; Senge T; Schenck B; Neumann F
    Acta Endocrinol (Copenh); 1979 Jun; 91(2):373-84. PubMed ID: 88858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of aromatase inhibitors on the functional morphology of the pituitary gland of dogs and monkeys.
    Habenicht UF; el Etreby MF
    Pathol Res Pract; 1988 Sep; 183(5):651-3. PubMed ID: 3237553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5 alpha-reductase activity in stroma and epithelium of rat prostate and epididymis. A contribution to elucidation of the mechanism for development of hyperplastic growth of prostatic tissue.
    Djøseland O; Bruchovsky N; Rennie PS; Otal N; Høglo S
    Acta Endocrinol (Copenh); 1983 Jun; 103(2):273-81. PubMed ID: 6190338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morphometric analysis of prostates in castrated dogs after treatment with androstanediol, estradiol, and cyproterone acetate.
    Tunn UW; Schüring B; Senge T; Neumann F; Schweikert HU; Rohr HP
    Invest Urol; 1981 Jan; 18(4):289-92. PubMed ID: 6161104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a model for the induction of estrogen-related prostatic hyperplasia in the dog and its response to the aromatase inhibitor 4-hydroxy-4-androstene-3,17-dione: preliminary results.
    Habenicht UF; Schwarz K; Schweikert HU; Neumann F; el Etreby MF
    Prostate; 1986; 8(2):181-94. PubMed ID: 2419882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of aging on kinetic parameters of 5 alpha-reductase in epithelium and stroma of normal and hyperplastic human prostate.
    Tunn S; Hochstrate H; Grunwald I; Flüchter SH; Krieg M
    J Clin Endocrinol Metab; 1988 Nov; 67(5):979-85. PubMed ID: 2460487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atamestane: an aromatase inhibitor for the treatment of benign prostatic hyperplasia. A short review.
    el Etreby MF
    J Steroid Biochem Mol Biol; 1993 Mar; 44(4-6):565-72. PubMed ID: 7682838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.